Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Michael Rocca Insider Profile
4 Followers
Michael Rocca, Director at St Jude Medical, holds 20.22K shares in Hyatt Hotels (Ticker: H), holds 21.21K shares in St Jude Medical (Ticker: STJ), holds 11.68K shares in Ligand Pharma (Ticker: LGND).
Profitable Transactions
1 out of 3 Profitable Transactions
Average Return
-5.70%
Average return per transaction
Time Frame
Compare to
Insider Holdings
Insider Roles
Most Profitable Insider Trade
Stock:
St Jude Medical
(STJ)
(STJ)
Rating:Informative Sell
Date:Feb 12, 2015 - Feb 12, 2016
Return:+23.20%
The most profitable trade made by Michael Rocca
Michael Rocca's Trading History
St Jude Medical
Jan 06, 2017
―
Uninformative Sell
―
$1.71M
Hyatt Hotels
Apr 01, 2024
Director
Uninformative Buy
―
$3.01M
Ligand Pharma
―
Director
―
$833.90K
List of latest transactions for each holding click on a transaction to see Michael Rocca's performance on stock
You May Also Like
Michael Rocca insider profile FAQ
What is the percentage of profitable transactions made by Michael Rocca?
The percentage of profitable transactions made by Michael Rocca is 33%.
What is the average return per transaction made by Michael Rocca?
The average return per transaction made by Michael Rocca is -5.70%.
What stocks does Michael Rocca hold?
Michael Rocca holds: STJ, H, LGND stocks.
What was Michael Rocca’s latest transaction?
Michael Rocca latest transaction was an Uninformative Buy of ―.
What was Michael Rocca's most profitable transaction?
Michael Rocca’s most profitable transaction was an Informative Sell of STJ stock on February 12, 2015. The return on the trade was 23.20%.
What is Michael Rocca's role in St Jude Medical?
Michael Rocca's role in St Jude Medical is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.